Literature DB >> 10516660

Differential effects of bepridil on functional properties of troponin C in slow and fast skeletal muscles.

P Kischel1, L Stevens, Y Mounier.   

Abstract

1. Bepridil (BPD) is a pharmacological compound able to bind to the Ca2+ sensor protein troponin C (TnC), which triggers skeletal muscle contraction upon Ca2+-binding. BPD can thereby modulate the Ca2+-affinity of this protein. 2. The Ca2+-sensitizing action of bepridil was investigated on slow and fast isoforms of TnC from skinned slow and fast skeletal muscle fibres, activated by either Ca2+ or Sr2+ ions. 3. Bepridil did not modify the Ca2+ maximal tension of slow and fast fibres, suggesting that binding of the drug to TnC did not induce a change in the number of cross-bridges involved in maximal tension. 4. Sr2+ ions induced lower maximal tension than Ca2+ ions. However, in fast fibres, these lower Sr2+ maximal tensions could be reinforced by bepridil, suggesting an effect of bepridil on the function of site I of fast TnC. 5. Under submaximal tension, bepridil induced an increase in Ca2+ affinity of TnC in both slow and fast fibres. However, slow fibres were more drug reactive than fast fibres, and the increase in tension appeared to be modulated by the Ca2+ concentration. 6. Thus, bepridil exerted a differential effect on slow and fast fibres. Moreover, the results suggest that bepridil was more effective when activation conditions were unfavourable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516660      PMCID: PMC1571663          DOI: 10.1038/sj.bjp.0702820

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  Molecular mechanism of troponin-C function.

Authors:  Z Grabarek; T Tao; J Gergely
Journal:  J Muscle Res Cell Motil       Date:  1992-08       Impact factor: 2.698

2.  Calcium-induced structural transition in the regulatory domain of human cardiac troponin C.

Authors:  L Spyracopoulos; M X Li; S K Sia; S M Gagné; M Chandra; R J Solaro; B D Sykes
Journal:  Biochemistry       Date:  1997-10-07       Impact factor: 3.162

3.  On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents.

Authors:  J W Herzig; U Quast
Journal:  Z Kardiol       Date:  1992

4.  Effect of troponin C on the cooperativity in Ca2+ activation of cardiac muscle.

Authors:  J Gulati; S Scordilis; A Babu
Journal:  FEBS Lett       Date:  1988-08-29       Impact factor: 4.124

5.  A model for the Ca2+-induced conformational transition of troponin C. A trigger for muscle contraction.

Authors:  O Herzberg; J Moult; M N James
Journal:  J Biol Chem       Date:  1986-02-25       Impact factor: 5.157

6.  Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle.

Authors:  M D Delp; C Duan
Journal:  J Appl Physiol (1985)       Date:  1996-01

7.  Force-pCa relation and troponin T isoforms of rabbit myocardium.

Authors:  R Nassar; N N Malouf; M B Kelly; A E Oakeley; P A Anderson
Journal:  Circ Res       Date:  1991-12       Impact factor: 17.367

8.  Calcium binding and tension development in detergent-treated muscle fibers.

Authors:  M Orentlicher; J P Reuben; H Grundfest; P W Brandt
Journal:  J Gen Physiol       Date:  1974-02       Impact factor: 4.086

Review 9.  The troponin complex and regulation of muscle contraction.

Authors:  C S Farah; F C Reinach
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

10.  Reciprocal coupling between troponin C and myosin crossbridge attachment.

Authors:  A S Zot; J D Potter
Journal:  Biochemistry       Date:  1989-08-08       Impact factor: 3.162

View more
  6 in total

1.  The role of the Ca(2+) regulatory sites of skeletal troponin C in modulating muscle fibre reactivity to the Ca(2+) sensitizer bepridil.

Authors:  P Kischel; B Bastide; J D Potter; Y Mounier
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Targeting the sarcomere to correct muscle function.

Authors:  Peter M Hwang; Brian D Sykes
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

3.  Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog.

Authors:  Sandra E Pineda-Sanabria; Ian M Robertson; Yin-Biao Sun; Malcolm Irving; Brian D Sykes
Journal:  J Mol Cell Cardiol       Date:  2016-02-04       Impact factor: 5.000

Review 4.  Novel myosin-based therapies for congenital cardiac and skeletal myopathies.

Authors:  Julien Ochala; Yin-Biao Sun
Journal:  J Med Genet       Date:  2016-07-13       Impact factor: 6.318

5.  Early Deconditioning of Human Skeletal Muscles and the Effects of a Thigh Cuff Countermeasure.

Authors:  Théo Fovet; Corentin Guilhot; Laurence Stevens; Valérie Montel; Pierre Delobel; Rémi Roumanille; Michel-Yves Semporé; Damien Freyssenet; Guillaume Py; Thomas Brioche; Angèle Chopard
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

6.  3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP.

Authors:  Svetlana B Tikunova; Andres Cuesta; Morgan Price; Monica X Li; Natalya Belevych; Brandon J Biesiadecki; Peter J Reiser; Peter M Hwang; Jonathan P Davis
Journal:  J Gen Physiol       Date:  2018-11-15       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.